# Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581

> **NCT02567370** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 70 (actual)

## Conditions studied

- Schizophrenia or Schizoaffective Disorder

## Interventions

- **DRUG:** AMG 581
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02567370
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2015-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02567370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02567370, "Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02567370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*